In a study conducted by Moore et al (2002, pp. 1145-7) entitled “Nurse Led Follow Up and Conventional Medical Follow Up in Management of Patients with Lung Cancer: Randomised Trial,” the researchers concluded that nurse led follow up care didn’t increase cost or risk to patient, yet delivered higher patient satisfaction and decreased burden on hospitals…
A collaborative study was used to determine whether a nurse led follow up service for lung cancer patients was more effective than the conventional medical follow up services offered through the outpatient clinics. The hypothesis was that this type of service would enhance care, reduce costs and increase patient quality of life. According to Van Tulder et al (1997, p. 2324), outcomes measuring patient care should include pain, functional status, ability to work and satisfaction with treatment, all of which are addressed in this study. Although this isn’t clearly stated, it is relevant in that it addressed a number of these variables. Some subsequent studies into the effectiveness of home care versus outpatient clinic care such as “Routine hospital admission versus outpatient or home care in children at diagnosis of type 1 diabetes mellitus” (Clar, Waugh, Thomas, 2003) yielded inconclusive results regarding the benefits of in-home care versus outpatient care while others, such as “Care home versus hospital and own home environments for rehabilitation of older people” (Ward, Severs, Dean, Brooks, 2003), suggest there is still not enough completed research to provide accurate, reliable results. ...
Cite this document
(“Moore Nurse Led Follow Up and Conventional Medical Follow Up in Essay”, n.d.)
Retrieved from https://studentshare.net/nursing/314143-moore-nurse-led-follow-up-and-conventional-medical-follow-up-in-management-of-patients-with-lung-cancer-randomised-trial
(Moore Nurse Led Follow Up and Conventional Medical Follow Up in Essay)
“Moore Nurse Led Follow Up and Conventional Medical Follow Up in Essay”, n.d. https://studentshare.net/nursing/314143-moore-nurse-led-follow-up-and-conventional-medical-follow-up-in-management-of-patients-with-lung-cancer-randomised-trial.
Milligan and Robinson (2003) claim the risk of harm has been significantly higher in the recent years. They claim that error or critical incidents happen in around 10% of admissions. They assert that medical decisions, drugs, and even medical devices reportedly harm more patients.
Lung cancer is usually associated with the elderly people due to its first metastasis process within the body (Roth, Cox & Hong 2). Study proves that the number of deaths in United States resulting from Lung cancer is greater than all the other types of cancers combined (Argiris, 118).
In 2012, the American cancer society estimated that over 226, 160 cases of cancer are anticipated by the end of the year and that 160, 340 deaths are expected to occur within the course of this year (5). The fatality of this disease has triggered a wide range of research to reveal the causes and predisposing factors of this disease as a core part of the fight against cancer in the world today.
Environmental, or second-hand, tobacco smoke is also implicated in causing lung cancer. Beta-carotene which serves as an antioxidant help deactivate free radicals, unstable molecules that are the by-products of cells "burning" oxygen for energy when used by smokers increases the risk of lung cancer and when used by a non-smoker prevents heart diseases.
There are various causes for lung cancer and the number of deaths in the world occurring due to this disease is increasing. It appears in various phases and spreads rapidly. There are preventive measures and appropriate treatment available to cure this disease.
It is a major health care problem due to the largely held belief that a highly painful death is inescapable in cancer which contributes to the patients’ anxiety. Such misconceptions, besides giving rise to an enhanced sense of
Cancer-related deaths are numerous worldwide. Among all types of cancer, lung cancer tops the list of cancer-related deaths. Cancer refers to the uncontrolled growth of abnormal cells. Lung cancer is, therefore, the uncontrolled growth of abnormal cells in both or one of the lungs. For cancer to be termed as lung cancer.